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Background: Accurate and timely malaria data are crucial to monitor the progress towards and attainment of
elimination. Lusaka, the capital city of Zambia, has reported very low malaria prevalence in Malaria Indicator Surveys.
Issues of low malaria testing rates, high numbers of unconfirmed malaria cases and over consumption of anti-malarials
were common at clinics within Lusaka, however. The Government of Zambia (GRZ) and its partners sought to address
these issues through an enhanced surveillance and feedback programme at clinic level.
Methods: The enhanced malaria surveillance programme began in 2011 to verify trends in reported malaria, as well as
to implement a data feedback loop to improve data uptake, use, and quality. A process of monthly data collection and
provision of feedback was implemented within all GRZ health clinics in Lusaka District. During clinic visits, clinic
registers were accessed to record the number of reported malaria cases, malaria test positivity rate, malaria testing rate,
and proportion of total suspected malaria that was confirmed with a diagnostic test.
Results and discussion: Following the enhanced surveillance programme, the odds of receiving a diagnostic test for a
suspected malaria case increased (OR = 1.54, 95 % CI = 0.96–2.49) followed by an upward monthly trend (OR = 1.05,
95 % CI = 1.01–1.09). The odds of a reported malaria case being diagnostically confirmed also increased monthly
(1.09, 95 % CI 1.04–1.15). After an initial 140 % increase (95 % CI = 91–183 %), costs fell by 11 % each month
(95 % CI = 5.7–10.9 %). Although the mean testing rate increased from 18.9 to 64.4 % over the time period, the
proportion of reported malaria unconfirmed by diagnostic remained high at 76 %.
Conclusions: Enhanced surveillance and implementation of a data feedback loop have substantially increased malaria
testing rates and decreased the number of unconfirmed malaria cases and courses of ACT consumed in Lusaka District
within just two years. Continued support of enhanced surveillance in Lusaka as well as national scale-up of the system
is recommended to reinforce good case management and to ensure timely, reliable data are available to guide
targeting of limited malaria prevention and control resources in Zambia.
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Data-driven decision-making amongst national malaria
control programmes in Africa is critical for the efficient
use of resources among an often increasingly stratified
malaria burden. Despite the need for improved informa-
tion, routine malaria surveillance throughout sub-Saharan
Africa is known to have many challenges including under-
representation of the true burden of malaria circulating in
communities [1–3], as well as lacking quality and timely
data reporting. As malaria control programmes pursue
malaria elimination, timely, reliable data becomes crucial
to respond to potential resurgence and to target foci of
malaria transmission with appropriate interventions [4, 5].
Improvements in Health Management Information
Systems (HMIS) are needed in order to provide quality
data necessary for a responsive malaria programme [6,
7]. However, national malaria control programme data
are often from population-based surveys conducted at
intervals of two years or more, rather than relying upon
surveillance data from continuously operating health in-
formation systems [8, 9]. Scaling up and integrating the
reporting of diagnostic confirmations of malaria cases has
the potential to significantly reduce malaria reporting
and unnecessary anti-malarial treatment administra-
tion, especially in areas with variable malaria transmis-
sion patterns [10].
The HMIS in Zambia collects and monitors health-
related indicators through paper-based reporting systems
collected on a monthly basis. Although collecting accur-
ate and timely data has been a goal of the Government
of Zambia (GRZ) since the inception of the HMIS, oper-
ational challenges remain. These include inadequate
support for training of especially new facility staff on
reporting standards and processes; infrequent supervi-
sion, especially amongst more rural, and distant facilities;
and insufficient data validation across multiple reporting
forms [11]. The lack of consistent feedback to health fa-
cilities regarding data quality and trends has previously
been identified in an assessment of the HMIS system
[11]. Furthermore, the time from a patient encounter at
a clinic to receipt of those data at the central level can
take weeks or even months.
In response to some of these challenges, the Ministry
of Health (MOH) recently began implementing the Dis-
trict Health Information System 2 (DHIS2), a central-
ized, web-based aggregate reporting system at national,
provincial, and district level to expedite data access and
reporting. The DHIS2 data flow model improves access
to information and timeliness from the point of data
entry. It further allows greater functionality for report-
ing, feedback, and communication among system users.
As the basis for aggregate reporting, DHIS2 was also
used by the National Malaria Control Programme
(NMCP) for data reporting from facility and communitylevels in areas of low malaria burden in support of the
National Malaria Strategic Plan goal to bring areas closer
to malaria elimination [12].
To further improve the accuracy and timeliness of
malaria data and to understand the true malaria burden
within all GRZ health facilities within Lusaka District,
the NMCP, and its partners initiated an enhanced surveil-
lance programme in 2010. This paper examines trends in
malaria indicators before and after the enhanced surveil-
lance programme, and assesses the benefits these invest-




Lusaka District, located in the southern area of the cen-
tral plateau of Zambia and home to the capital city
Lusaka with an estimated population of 1.7 million, is
the most urbanized area of the country. Lusaka District
alone represents approximately 14 % of the national
population and therefore resource allocation for malaria
control efforts for Lusaka greatly affects national plan-
ning efforts. Recent survey reports suggest that Lusaka
Province, including areas in Lusaka District are amongst
the lowest malaria prevalence areas in Zambia, with less
than 1 % malaria parasite prevalence reported in chil-
dren under the age of 5 over the past 8 years [13–16].
Although indoor residual spray campaigns have been
conducted since 2003, the distribution of long lasting in-
secticide treated nets (through mass distributions, at
antenatal clinics, and at clinics for children under 5) as
well as the use of artemisinin combination therapy (ACT)
for clinical management of malaria are considered by
some to be major contributing factors to low malaria
prevalence [17]. Low malaria prevalence in Lusaka is also
likely an outcome of the rapid rate of urbanization and
high altitude [18, 19]. Routine HMIS data in Lusaka,
Zambia reported 171,578 malaria cases (cumulative inci-
dence (CI) = 104 cases per 1,000 population) in 2009 and
221,244 malaria cases (CI = 119 cases per 1000 popula-
tion) in 2010.
Enhanced surveillance
To address challenges encountered within the HMIS
and to improve the accuracy and consistency of data, an
enhanced surveillance programme was initiated in all 26
public health facilities in Lusaka District beginning No-
vember 2010. The enhanced surveillance programme in-
cluded four components: 1) retrospective record reviews
of patient registers, tally sheets, and stock control cards
to understand accuracy and process issues with reported
malaria data; 2) prospective data collection using im-
proved forms and reporting accountability measures at fa-
cility level; 3) improved quality assurance for diagnostic
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cians and the NMCC; and 4) consistent and timely report-
ing and feedback from the NMCC to the district and
facility staff of results of prospectively collected informa-
tion and quality assurance results.
Initially, retrospective malaria data were collected
(January 2004 to March 2011) from each health facility
in Lusaka District from a small team of data collectors.
Due to high levels of incompleteness, only data starting
from January 2009 were used in analyses. Data sources
consulted included outpatient disease (OPD) registers,
RDT registers, laboratory registers, stock control cards,
and HMIS disease aggregation forms which are used to
aggregate monthly facility data sent through the HMIS
every month. Data collected included total consultations,
total reported malaria, total malaria rapid diagnostic tests
(RDTs) administered, total malaria microscopy slides
collected, total confirmed malaria positives by RDT or
microscopy, and total artemisinin combination therapy
(ACT) courses dispensed. These data elements were
adapted from a tool used by the PATH Malaria Control
and Elimination Partnership in Africa (MACEPA) in other
districts of Zambia [10]. The number of confirmed malaria
cases reporting recent (within one month) travel history
outside Lusaka District was also collected from clinic re-
cords starting in January 2012.
Supervision and feedback
Between April 2011 and December 2012, the latest malaria
data recorded in clinic logbooks was compared with re-
ported numbers during monthly supervision visits, and
feedback was provided to health facility staff on the previ-
ous month’s data. Clinicians, nurses, and laboratory staff
were instructed on correct data definitions and reporting
standards and were kept informed of their progress in ad-
hering to national guidelines for treatment and reporting
(e.g., dispensing anti-malarials only based on diagnostic
confirmation). Areas in which improvements could be
made were identified and corrected, such as use of case
definitions or data recording practices. During monthly
clinic visits, the data collection team provided reports to
laboratory and clinic staff on their performance relative to
other Lusaka District clinics. In addition, meetings be-
tween NMCP officers coordinating this activity and Dis-
trict Health Management Team (DHMT) staff were used
to further disseminate information on the district malaria
situation. These meetings brought the data to the forefront
and helped foster an environment where the accuracy and
quality of the data were considered important and helpful
for decision-making.
Laboratory quality assurance
The enhanced surveillance programme team partnered
with the NMCP parasitology department to collect malarialaboratory quality assurance data. Each month all positive
malaria blood slides as well as a sample of ten negative
slides from each health facility were collected and re-
examined by NMCP parasitology experts. RDT cassettes
were also reviewed and compared to results, which clinic/
lab staff had recorded. Week-long refresher training for all
laboratory staff that included parasite detection, quanti-
fication, and Plasmodium spp. identification with WHO-
approved reference slides was also provided. These
trainings were conducted in May 2011 and included
an additional component on malaria case management
provided to at least one clinician from each health fa-
cility. These activities were all aimed at improving the
accuracy of malaria diagnosis, case management, and
ultimately, malaria surveillance.
Data analysis
The benefits of enhanced surveillance activities were
assessed through trend analysis using clinic-reported
data collected during these activities. Four outcomes of
principle interest were considered: the malaria test posi-
tivity rate, the malaria testing rate, the proportion of un-
confirmed malaria, and costs associated with malaria
diagnosis and ACT treatment. The malaria test positivity
rate was defined as the number of malaria cases con-
firmed with RDTs or microscopy divided by the number
of suspected malaria cases tested with RDTs or micros-
copy. The malaria testing rate was defined as the propor-
tion of suspected malaria cases that were tested by
either RDTs or microscopy. The proportion of uncon-
firmed malaria was defined as the number of reported
malaria cases without diagnosis by RDT or microscopy
divided by the number of total reported malaria cases.
Median costs associated with malaria diagnosis were de-
fined as $0.77 per 1,000 microscopy tests and $325 per
1,000 RDTs. Median costs associated with malaria treat-
ment were defined as $800 per 1,000 ACTcourses (NMCP
personal communication). Differences in the outcomes be-
fore and after the implementation of enhanced surveil-
lance were tested (2009–10 compared to 2011–12) by an
interrupted time series analysis with health facility used as
a random intercept. Total outpatient attendance and mal-
aria transmission season were controlled by including
monthly outpatient attendance and whether or not the
month was part of the malaria transmission season which
is assumed to be December – May. For the outcome of
malaria test positivity, vector abundance was controlled
for using the mean enhanced vegetation index (EVI) de-
rived from MODIS satellites in a 2 km radius around each
health centre. The relationship between enhanced surveil-
lance data and routine HMIS was determined using
Pearson’s correlation and a Z-test following Fisher’s Z
transformation to compare correlation coefficients be-
fore and after implementation of enhanced surveillance.
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to extract EVI for Lusaka District. All analyses were con-
ducted using STATA 10.0 (College Station, TX), and R
version 3.1.0 [21].
Results
Data completeness of the enhanced surveillance programme
exceeded 95 % for the study period. The enhanced surveil-
lance system also allowed clinic data to be reviewed imme-
diately upon monthly collection at the health facility,
compared to a lag of three to six months or longer, which
was common at that time within the routine HMIS sys-
tem. Aggregated reported number of malaria cases in
Lusaka District declined from 204,827 in 2009 to 130,374
in 2012 in conjunction with an actual decrease in the pro-
portion of outpatients reported as malaria from 30.35 % in
2009 to 11.55 % in 2012 (Table 1).
Test positivity
Test positivity at each facility rarely exceeded 10 % even
in the high transmission season (Fig. 1). The odds of an
individual testing positive for malaria were 2.86 times
greater in the high transmission season than in the dry
season (Odds Ratio (OR) = 2.86, 95 % CI = 2.30–3.56).
The enhanced vegetation index was not associated with
test positivity (Table 2). From 2009 to 2010, results sug-
gest a moderate decreasing trend of test positivity with
the odds of testing positive decreasing by 0.024 each month
(p = 0.092). From 2011 to 2012 results suggest an increas-
ing trend in test positivity with the odds of testing positive
increasing by 0.042 each month (p = 0.026) (Table 2).
Improved testing rates
Before the implementation of the enhanced surveillance
programme, 18.94 % of suspected malaria cases were
tested with either microscopy or an RDT. Following the
implementation of the enhanced surveillance programme,
testing rates increased to 64.41 % with an immediate
increase in January 2011 (Fig. 2a). The interrupted time
series results suggest that the enhanced surveillance
programme had a large impact on testing rates; the OR
for a suspected malaria patient being tested was 1.54
(95 % CI = 0.96–2.49) following the introduction of the
enhanced surveillance programme (Table 3). There wasTable 1 Total outpatient and malaria indicators reported through th
2009–2012
Year Total outpatient consultations Reported malaria cases Perce
repor
2009 674,824 204,827 30.35
2010 887,477 307,242 34.62
2011 911,230 209,945 23.04
2012 1,128,320 130,374 11.55no trend in testing rates before the enhanced surveillance
programme (p = 0.487), but following its introduction, the
odds of receiving a diagnostic test increased to 1.048 per
month (p = 0.023).Reporting confirmed malaria
In conjunction with the rising testing rates, the proportion
of reported malaria that was unconfirmed by microscopy
or RDT fell from 98.33 % before the implementation of
the enhanced surveillance programme to 76.32 % after
(Fig. 2b). The interrupted time series results suggest there
was no change in the odds of a reported case being
confirmed diagnostically before the enhanced surveil-
lance programme (p = 0.511), and an increase of 0.090
per month in the odds of a reported case being con-
firmed following the intervention (p = 0.002). Reported
malaria cases were more likely to be confirmed during
the wet season (OR = 2.57, 95 % CI = 2.12–3.12) and
with lower total outpatient attendance (Table 4).Malaria-related costs
ACT consumption also decreased from 242,140 in 2010
to 119,790 in 2012. Lab diagnostic costs increased dur-
ing this time period in conjunction with the testing rates.
The interrupted time series results suggest that before the
implementation of the enhanced surveillance programme,
malaria costs were rising approximately 8.3 % per month
(Table 5). Immediately following the implementation of
the enhanced surveillance programme, malaria costs were
higher than before the enhanced surveillance programme,
but thereafter decreased 11.2 % each month.Agreement between HMIS data and clinic records
Prior to the initiation of enhanced surveillance, there
was only a moderate correlation (total malaria, r = 0.476)
between data recorded in clinic registers and the num-
ber of malaria cases actually reported to the HMIS
(Fig. 3). During the enhanced surveillance period, these
two datasets became not only more correlated (total
malaria, r = 0.810), but the correlation increase was sig-
nificant (z-score = −1.974, p = .048).e enhanced surveillance programme in Lusaka, Zambia
nt outpatient consultations
ted as malaria
Mean testing rate Mean test positivity
% 18.94 % 6.41 %
% 25.02 % 4.36 %
% 51.04 % 4.26 %
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Fig. 1 Range of malaria test positivity by month from 2009 to 2012 at all health facilities in Lusaka, Zambia. There were no differences in malaria
test positivity by year
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Clear benefits of the enhanced surveillance programme
were observed during its implementation: a significant
increase in the number of suspected cases being tested
and a decrease in reported cases going unconfirmed.
Costs associated with malaria treatment and diagnosis
initially increased as testing rates increased with the im-
plementation of the enhanced surveillance programme.Table 2 Results from interrupted time series regression assessing th






Enhanced Vegetation Index 1st tertile
2nd tertile
3rd tertile
N = 26 facilities and 548,158 suspected cases testedHowever, the initial rise in cost was followed by a steady
downward trend of 11.2 % per month. Prior to the en-
hanced surveillance programme, costs had been rising
by 8.3 % per month. With 80 % of reported malaria still
unconfirmed through diagnostics and a typical test posi-
tivity < 10 %, further cost savings can be obtained if
more unconfirmed malaria cases are tested first and not
given ACT if testing negative.e odds of testing positive for malaria in Lusaka District from
a at the clinic level



























































Facility expenditures on ACTs
a b
c d
Fig. 2 Clockwise from top left: a malaria testing rate, b proportion of reported malaria cases unconfirmed by microscopy or RDT, c proportion of
total OPD that was reported as malaria, and d mean cost in ACT courses dispensed at each public clinic within Lusaka District from 2009 to 2012.
Price of ACT in USD by pack size: 6′s = $0.36; 12′s = $0.72; 18′s = $1.08; 24′s = $1.30 (Medicine for Malaria Venture, USAID|Deliver, Zambia)
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fell considerably. The largest decline was seen in the
number of clinical malaria cases, those thought to be
malaria by the clinical staff but which did not receive a
confirmatory malaria test. The decrease in clinical mal-
aria cases likely do not represent an actual decrease in
true malaria burden, as test positivity actually increasedTable 3 Results from interrupted time series regression assessing th
District before and after the intervention of enhanced surveillance a








Total outpatient attendance Per 1,000
N = 26 facilities and 1,345,978 suspected malaria casesslightly. Rather, the enhanced surveillance programme
likely contributed to increased confidence in the use of
parasitological confirmations among patients by clini-
cians and increased perception among facility staff that
malaria is not a significant problem in the district
resulting in much fewer clinical malaria cases being
reported.e odds of suspected cases being tested for malaria in Lusaka
nd feedback loop. Standard errors have been adjusted for








Table 4 Results from interrupted time series regression assessing the odds of reported malaria cases being confirmed via rapid
diagnostic test or microscopy for malaria in Lusaka District before and after the intervention of enhanced surveillance and feedback
loop. Standard errors have been adjusted for correlated data at the clinic level
Factor Odds ratio (95 % confidence interval) p-value
Intervention Pre-intervention Reference
Post-intervention 1.206 (0.367–3.962) 0.748
Monthly trend Pre-intervention 0.987 (0.949–1.027) 0.511
Post-intervention 1.090 (1.036–1.146) 0.002
Season Dry Reference
Wet 2.571 (2.122–3.116) <0.001
Total outpatient attendance Per 1,000 0.919 (0.867–0.975) 0.007
N = 26 facilities and 851,574 reported malaria cases
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mains a major issue in Lusaka. In 2013, for example,
68 % of the 58,400 clinical cases reported in Lusaka Dis-
trict were reported from just 6 clinics (23 %). Greater
outpatient attendance was associated with decreased
odds of receiving a malaria diagnostic test and decreased
odds that reported malaria was diagnostically confirmed.
Among the clinics with persistently high rates of report-
ing unconfirmed malaria, the ability of facility staff to
provide testing services to the number of patients seen
remains a challenge. As the population growth of Lusaka
outstrips the growth of more clinics and services, delays
in receiving malaria diagnostics may increase. Where
clinics struggle to offer testing services, screening at
clinic registration, or shifting testing services to commu-
nity level may be strategic solutions to improve malaria
diagnostic and treatment rates.
Regular discussions with health facility staff during the
feedback sessions influenced the perception of the mal-
aria burden in their catchments. Prior to the initiation of
the programme, health staff would comment on the high
levels of malaria seen within their catchments; however,
as the programme progressed, clinic staff directly ob-
served data showing an increase in diagnostic use was
associated with a decrease in unconfirmed reported mal-
aria and the number of ACT dispensed. By the end of
2012, many staff recognised that the true burden ofTable 5 Results from interrupted time series regression assessing th
and treatment in Lusaka District before and after the intervention of








N = 26 facilities and 1,236 facility-monthsmalaria was actually very low. It is worth noting that the
laboratory training and mentorship provided likely con-
tributed to the success of the feedback sessions, highlight-
ing that a multi-partner framework drawing on specialist
areas contributes to the success of surveillance pro-
grammes. Given this observed change, evidence-driven
communication campaigns targeting health worker per-
ceptions of malaria burden and the importance of diag-
nostic testing may be appropriate in reducing perceived
malaria burden in other areas with similar malaria
transmission and burden profiles as Lusaka district.
Despite testing rates exceeding 60 % following the im-
plementation of enhanced surveillance, the proportion of
malaria reported that was actually confirmed remained
quite low at 24 %. In areas of low transmission such as in
Lusaka, Zambia, with test positivity among suspected inci-
dent cases < 10 % throughout the year, unconfirmed re-
ported malaria cases are not likely to be actual malaria
cases. Misdiagnosing these individuals and giving them
ACT presents two serious problems. First, in areas of low
transmission such as Lusaka, the patient is likely not
treated for the illness that prompted them to seek care. As
an example of the problem of over prescription of ACT, in
an area of Tanzania with a similar malaria test positivity
rate as reported in Lusaka, respiratory infections treatable
with antibiotics were the most common cause of fever
among outpatients seeking care [22] Treating thesee monthly log-transformed costs associated with malaria testing
enhanced surveillance and feedback loop. Standard errors have
Coefficient (95 % confidence interval) p-value
Reference
1.398 (0.913 – 1.83) <0.001
0.083 (0.057 – 0.109) <0.001
−0.112 (−0.147 – −0.077) <0.001
Reference
0.952 (0.752 – 1.151) <0.001
Fig. 3 Comparison of total malaria cases reported through standard HMIS versus data collected through monthly supervision and review of clinic
registers during the enhanced surveillance system (ES). Graph includes data from before and after the implementation of monthly enhanced
surveillance system visits in 2011. Prior to the start of enhanced surveillance system, HMIS, and enhanced surveillance data were only moderately
correlated compared to after, where correlation increased significantly
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but at worst may in fact increase morbidity and mortality
[23]. Second, prescribing, and consuming drugs in the
absence of the condition that they treat is a waste of
money particularly egregious in resource-deprived set-
tings. Understanding the aetiology and clinical diagno-
sis of non-malaria fevers is therefore a critical step in
further reducing reported malaria and in improving
patient care in Lusaka District.
Pressure to give a malaria diagnosis is multifaceted
and includes a clinician’s treatment preferences, pressure
from patients to receive medicine for an illness, avail-
ability of different medications, and the potential severity
of missing a malaria infection [24]. Anecdotally, health
practitioners in Lusaka District have indicated they are
often pressured into prescribing anti-malarials in the ab-
sence of, or in spite of a negative diagnostic test result,
by their patients. It is possible that overconsumption is a
reflection of the paucity of treatments available foralternative diagnoses (e.g., antibiotics for respiratory in-
fections). For example, when patients were provided
with test results and alternative treatments in the case of
negative malaria tests in Tanzania, patient pressure for
anti-malarials reduced greatly [25]. A diagnostic algo-
rithm requiring laboratory-confirmation for malaria in-
fection before patients receive an anti-malarial has been
implemented within Chelstone Clinic in Lusaka, result-
ing in a 65 % reduction in ACT courses dispensed be-
tween 2011 and 2012. Behaviour change communication
campaigns to educate the community and urge patients
to insist on receiving a diagnostic confirmation as well
as modify the common perception that “fever equals
malaria” could potentially help continue to reduce ACT
over-consumption, as could behaviour change communi-
cation campaigns targeted toward clinicians.
Significant cost savings for the malaria control programme
have likely already accrued as a result of the enhanced sur-
veillance programme through reduced ACT dispensing.
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tinues to be much greater than the number of confirmed
malaria cases. Further addressing the barriers to clinical
reporting will improve the cost savings at the clinic level
as well as at the district and NMCP levels. Additional
benefit to the improved surveillance system has been a re-
duction in the allocation of other malaria resources to
Lusaka District, in favour of more malarious areas as well
as targeting of indoor residual spraying resources within
Lusaka (2014). Targeting malaria resources based on im-
provements in surveillance ensures more efficient use of
public and donor resources.
Given the low number of confirmed malaria cases
identified, an additional component has been added to
the enhanced surveillance programme: a reactive case
detection system whereby confirmed cases are followed
up to the household for foci detection and containment
(Larsen et al. in preparation). This measure has been im-
plemented to increase the sensitivity of the surveillance
system to detect community-level malaria infections. Al-
though Lusaka District has not been declared a malaria-
elimination zone within Zambia, travel history, and
other data necessary to substantiate malaria elimination
are being collected in the hope that this area will soon
report zero locally-acquired cases.
Progress towards both malaria control and eventual
elimination are underpinned by high quality routine sur-
veillance to determine the true malaria burden in an
area. Further, in malaria control areas, accurate data are
essential to know the overall burden of malaria as well
as to identify hotspot areas so intervention resources
can be applied wisely. The approach herein may be used
in the short term to improve data capture and reporting
practices, to increase adherence to best-practice policies,
to inform local practitioners on the true burden of mal-
aria in their area and to establish a robust foundation for
the introduction of other interventions. Although the
process of monthly supervision and data collection re-
quires additional manpower to accomplish, local data
clerks can be trained to systematically collect data, and
over time health facilities will become accustomed to
having record books available for monthly reviews. Fur-
ther, in 2013, MOH clinics within Lusaka District as well
as Southern, Central, and Western Province were transi-
tioned to a system of weekly mobile-phone reporting of
malaria data into the DHIS2, designed to support con-
tinued flow of accurate and timely malaria data [26].
Data transmitted include aspects of OPD attendance,
clinical, and confirmed malaria case numbers, testing
rates (RDT, and microscopy) and ACT consumption.
The utilization of this new system has improved the
timeliness of the data as well as provided a feedback
loop to ensure clinic staff can visualize data trends. Staff
at all levels of the health system are now able to login tothe DHIS2 to view a dashboard displaying malaria data,
which can highlight areas where specific clinics are achiev-
ing success in establishing high testing rates or reducing
overconsumption of ACT. Through the dashboard, as-
pects that need to be addressed at individual clinics are
visualized. Clinic staff can review malaria trends at
their clinic, as well as in comparison with other clinics.
Malaria data for the entire district, province, and nation
can also be reviewed and supervisors at all levels can
use this system as a supervisory tool. The rollout of weekly
reporting and DHIS2 in Lusaka District was intended, in
many ways, to replace the monthly supervision visits con-
ducted during the enhanced surveillance system. Initial
trends, however, indicate continued supervision at clinic
level is necessary, at least in some clinics, to maintain the
achievements in quality reporting made through this
programme. Continued work to identify best-practice
methods for ensuring health staff are reviewing and under-
standing data trends, and applying data knowledge to
every-day clinical practice are being explored. These may
include automated feedback mechanisms through DHIS2
and mobile phone technology to reduce the manpower re-
quired for consistent supervision visits. While private
clinics were not included in this programme, public-
private partnerships could be explored to ensure max-
imum data capture and harmonisation of best practices
across the entire country.
Conclusions
The enhanced surveillance programme initiated in Lusaka
District achieved its objectives of improving case manage-
ment and reporting of malaria. Most notably, the malaria
testing rate increased substantially despite having further
room for improvement. To ensure sustainability, and
avoid the creation of a parallel system, key features of the
programme, (e.g., feedback loops between clinic, and
DHMT, and rapid reporting mechanisms) are now being
incorporated into the HMIS via DHIS2. Systems such as
the one described here may be worthwhile to maintain
until improved data reporting practices take hold to deter-
mine the true burden of malaria in an area and to guide
decision making on how to allocate limited malaria pre-
vention and control resources.
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